Felix Theeuwes
No más puestos en curso
Perfil
Felix Theeuwes is the founder of DURECT Corp., which was founded in 1998.
He held the title of Chairman in 2018.
Dr. Theeuwes also held former positions as a Director at Genetronics Biomedical Corp.
and Inovio Pharmaceuticals, Inc. He was the President-New Ventures at ALZA Corp.
from 1982 to 1998.
Dr. Theeuwes received his undergraduate and graduate degrees from Katholieke Universiteit Leuven.
He also received a doctorate from Katholieke Universiteit Leuven in 1966.
Antiguos cargos conocidos de Felix Theeuwes.
Empresas | Cargo | Fin |
---|---|---|
DURECT CORPORATION | Founder | 31/12/2018 |
INOVIO PHARMACEUTICALS, INC. | Director/Board Member | 04/05/2007 |
Genetronics Biomedical Corp. | Director/Board Member | 05/04/2005 |
ALZA CORPORATION | Corporate Officer/Principal | 01/08/1998 |
Formación de Felix Theeuwes.
Katholieke Universiteit Leuven | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
DURECT CORPORATION | Health Technology |
INOVIO PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
ALZA Corp.
ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Genetronics Biomedical Corp. | Commercial Services |
- Bolsa de valores
- Insiders
- Felix Theeuwes